22 May 2013
Keywords: fda, heads-up, new, rx, ad, guidelines, part
Article | 14 March 2005
As part of concerted moves by the US Food and Drug Administration to take a tougher stance on direct-to-consumer drug ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
14 March 2005
28 February 2005
21 May 2013
© 2013 thepharmaletter.com